John D Olsen, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Scott Paul Davis, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Sandeep S Jain, MBBS Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Terence R Pladson, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave N, Saint Cloud, MN 56303 Phone: 320-251-2700 |
Justin Paul Stocks, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1406 6th Ave N, Saint Cloud, MN 56303 Phone: 909-222-7447 |
News Archive
Dr. Elisabetta Patorno, a research fellow at Brigham and Women's Hospital and Harvard Medical School in Boston has published a study this week in the Journal of American Medical Association which found that taking anticonvulsant drugs raise thoughts of suicide and risks of actually trying to commit suicide by two times the norm. The study was sponsored by the Harvard School of Public Health and HealthCore, a research subsidiary of WellPoint. WellPoint is a health benefits company that serves the Blue Cross Blue Shield network.
UK guidelines for alcohol consumption have been revised to bring them in line with current research findings. The revised guidelines, published today, state that there is not a safe limit for alcohol intake and that the risks are similar for men and women.
The University of Virginia Health System has opened a high-tech clinical genomics lab that will personalize care for patients, help doctors determine the best treatments for cancers and other diseases, and allow UVA to offer the most cutting-edge clinical trials.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, for $485 million in cash.
› Verified 6 days ago